AI assistant
Sending…
Vanda Pharmaceuticals Inc. — Director's Dealing 2010
Feb 19, 2010
33390_dirs_2010-02-19_fd732a14-888d-48ef-bdc5-b00d534374bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2010-02-18
Reporting Person: Irish Stephanie Rast (Acting CFO/Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-02-18 | Common Stock | M | 20000 | — | Acquired | 22449 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-18 | Restricted Stock Units | $ | M | 20000 | Disposed | Common Stock (20000) | Direct |
Footnotes
F1: The Restricted Stock Units represented a contingent right to receive a share of the Issuer's common stock which vested on December 31, 2009.
F2: N/A
More from Vanda Pharmaceuticals Inc.
Regulatory Filings
2026
Jun 5
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19